331 related articles for article (PubMed ID: 32397134)
1. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
Viruses; 2020 May; 12(5):. PubMed ID: 32397134
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
Villa NY; Franco LS; McFadden G
Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
[TBL] [Abstract][Full Text] [Related]
3. Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.
Torres-Domínguez LE; de Matos AL; Rahman MM; McFadden G
Methods Mol Biol; 2021; 2225():63-75. PubMed ID: 33108657
[TBL] [Abstract][Full Text] [Related]
4. RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.
Rahman MM; Gutierrez-Jensen AD; Glenn HL; Abrantes M; Moussatche N; McFadden G
J Virol; 2021 Jun; 95(14):e0015121. PubMed ID: 33952639
[TBL] [Abstract][Full Text] [Related]
5. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
[TBL] [Abstract][Full Text] [Related]
6. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.
Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL
Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686
[TBL] [Abstract][Full Text] [Related]
7. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
[TBL] [Abstract][Full Text] [Related]
8. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.
Wennier ST; Liu J; Li S; Rahman MM; Mona M; McFadden G
Mol Ther; 2012 Apr; 20(4):759-68. PubMed ID: 22233582
[TBL] [Abstract][Full Text] [Related]
9. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
[TBL] [Abstract][Full Text] [Related]
10. Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression.
Smallwood SE; Rahman MM; Werden SJ; Martino MF; McFadden G
Curr Protoc Microbiol; 2011 May; Chapter 14():Unit 14A.2. PubMed ID: 21538302
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variability of Myxoma Virus Genomes.
Braun C; Thürmer A; Daniel R; Schultz AK; Bulla I; Schirrmeier H; Mayer D; Neubert A; Czerny CP
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903800
[TBL] [Abstract][Full Text] [Related]
12. Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.
Peng C; Haller SL; Rahman MM; McFadden G; Rothenburg S
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3855-60. PubMed ID: 26903626
[TBL] [Abstract][Full Text] [Related]
13. Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
Stanford MM; Barrett JW; Gilbert PA; Bankert R; McFadden G
J Virol; 2007 Nov; 81(22):12704-8. PubMed ID: 17728229
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic myxoma virus: the path to clinic.
Chan WM; Rahman MM; McFadden G
Vaccine; 2013 Sep; 31(39):4252-8. PubMed ID: 23726825
[TBL] [Abstract][Full Text] [Related]
15. Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.
Rahman MM; Bagdassarian E; Ali MAM; McFadden G
Sci Rep; 2017 Nov; 7(1):15710. PubMed ID: 29146961
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Myxoma Virus C7-Like Host Range Factor That Enabled a Species Leap from Rabbits to Hares.
Águeda-Pinto A; Kraberger S; Everts A; Gutierrez-Jensen A; Glenn HL; Dalton KP; Podadera A; Parra F; Martinez-Haro M; Viñuelas JA; Varsani A; McFadden G; Rahman MM; Esteves PJ
mBio; 2022 Apr; 13(2):e0346121. PubMed ID: 35352978
[TBL] [Abstract][Full Text] [Related]
17. The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.
Liu J; Wennier S; McFadden G
Microbes Infect; 2010 Dec; 12(14-15):1144-52. PubMed ID: 20832500
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of myxoma virus as a new viral vector for small ruminants.
Pignolet B; Boullier S; Gelfi J; Bozzetti M; Russo P; Foulon E; Meyer G; Delverdier M; Foucras G; Bertagnoli S
J Gen Virol; 2008 Jun; 89(Pt 6):1371-1379. PubMed ID: 18474552
[TBL] [Abstract][Full Text] [Related]
19. Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication.
Rahman MM; Liu J; Chan WM; Rothenburg S; McFadden G
PLoS Pathog; 2013; 9(7):e1003465. PubMed ID: 23853588
[TBL] [Abstract][Full Text] [Related]
20. Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.
Kerr PJ; Eden JS; Di Giallonardo F; Peacock D; Liu J; Strive T; Read AF; Holmes EC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
